Bell Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.37M Buy
49,999
+366
+0.7% +$24.4K 0.9% 54
2026
Q1
$3.14M Sell
49,633
-12,540
-20% -$873K 0.93% 50
2025
Q4
$4.15M Buy
62,173
+30,725
+98% +$1.99M 1.11% 34
2025
Q3
$2.12M Buy
+31,448
New +$2.49M 0.58% 62

Other funds holding DXCM

Bell Asset Management's DXCM Position: Q2 2026 in Review

Bell Asset Management increased its DexCom (DXCM) stake by 0.74% in Q2 2026, buying an estimated $24.4K and bringing the position to 49,999 shares worth $3.37M. The position accounts for 0.9% of the portfolio, ranked #54.

Bell Asset Management first reported a position in DXCM in Q3 2025 and has held it in 4 quarters since. The position peaked at $4.15M in Q4 2025. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Bell Asset Management held 49,999 shares of DexCom worth $3.37M as of Q2 2026.
  • Bell Asset Management bought 366 DexCom shares in Q2 2026, an estimated $24.4K.
  • DexCom made up 0.9% of Bell Asset Management's portfolio in Q2 2026, its #54 holding.
  • Bell Asset Management first reported a position in DexCom in Q3 2025 and has held it in 4 quarters since.
  • Bell Asset Management's DexCom position peaked at $4.15M in Q4 2025.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Bell Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.